DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR VIRAMUNE XR
» See Plans and Pricing
All Clinical Trials for Viramune Xr
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00002166 | An Open-Label, Non-Randomized Trial to Evaluate the Tolerability and Safety of Viramune (Nevirapine) in Adult and Pediatric Patients With Progressive HIV Disease | Completed | Boehringer Ingelheim | Phase 3 | 1969-12-31 | To provide access to Viramune and to evaluate the tolerance and safety of Viramune in patients with progressive, symptomatic HIV disease who failed or are intolerant to currently approved treatment for HIV-1 infection and who are unable to participate in another Viramune controlled clinical trial and have a compelling need for anti-HIV treatment. |
NCT00002194 | An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4. | Completed | Boehringer Ingelheim | Phase 1 | 1969-12-31 | To evaluate the potential pharmacokinetic interaction between nevirapine and clarithromycin, and to determine the effects of nevirapine on cytochrome P450 3A4 (CYP3A4) activity in vivo. |
NCT00002368 | The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs | Completed | Boehringer Ingelheim | Phase 3 | 1969-12-31 | To evaluate the tolerance, safety, and effectiveness of Viramune in preventing clinical AIDS progression events or death when used in combination with Lamivudine and background nucleoside therapy. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Viramune Xr
Condition Name
Condition MeSH
Clinical Trial Locations for Viramune Xr
Trials by Country
Clinical Trial Progress for Viramune Xr
Clinical Trial Phase
Clinical Trial Sponsors for Viramune Xr
Sponsor Name